MCMedicalCodingSoftware
C77.1

C77.1: Secondary and unspecified malignant neoplasm of intrathoracic lymph nodes

Billable / specific codeICD-10-CM

C77.1 is a billable, specific ICD-10-CM code for secondary and unspecified malignant neoplasm of intrathoracic lymph nodes. It is valid for submission on a claim.

Check C77.1 with the rest of the claim: free scrubber

Excludes1 inherited from the categories above C77.1

A category’s note binds every code beneath it.

Written on C77: Secondary and unspecified malignant neoplasm of lymph nodes

  • malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
  • mesentery metastasis of carcinoid tumor (C7B.04)
  • secondary carcinoid tumors of distant lymph nodes (C7B.01)

Risk adjustment

C77.1 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

  • HCC 17 Cancer Metastatic to Lung, Liver, Brain, and Other Organs; Acute Myeloid Leukemia Except Promyelocytic4.209 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score. Look up the whole chart to see which of its HCCs the hierarchy would zero.

Medicare coverage

C77.1 is named in 42 Medicare coverage policies: 42 listing it as supporting medical necessity. Which one applies depends on your Medicare contractor.

  • A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
  • A52986Billing and Coding: Biomarkers for Oncology
  • A53101Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
  • A54188Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID®

Code history

Unchanged in every release from FY2024 to FY2027.

Other codes under C77

ICD-10-CMFY2027· effective October 1, 2026

Loaded directly from the CMS/NCHS ICD-10-CM public-domain release: see data sources and our editorial policy. If this page disagrees with the CMS tabular list, this page is wrong. Reference information for professional coders; not medical or billing advice.